Lompat ke konten Lompat ke sidebar Lompat ke footer
close

Postingan Terbaru

01 71 38 42 20 / Risk Of Admission To Hospital For Serious Infection After Initiating Tofacitinib Versus Biologic Dmards In Patients With Rheumatoid Arthritis A Multidatabase Cohort Study The Lancet Rheumatology

01 71 38 42 20 / Risk Of Admission To Hospital For Serious Infection After Initiating Tofacitinib Versus Biologic Dmards In Patients With Rheumatoid Arthritis A Multidatabase Cohort Study The Lancet Rheumatology

Voici quelques resumes de mots-cles pour vous aider a trouver votre reche… Baca selengkapnya 01 71 38 42 20 / Risk Of Admission To Hospital For Serious Infection After Initiating Tofacitinib Versus Biologic Dmards In Patients With Rheumatoid Arthritis A Multidatabase Cohort Study The Lancet Rheumatology
Posting Komentar